Skip to main content
Log in

Oxidative Modification and Poor Protective Activity of HDL on LDL Oxidation in Thalassemia

  • Original Article
  • Published:
Lipids

Abstract

Oxidative modification of low-density lipoprotein (LDL) has been reported in thalassemia, which is a consequence of oxidative stress. However, the levels of oxidized high-density lipoprotein (HDL) in thalassemia have not been evaluated and it is unclear whether HDL oxidation may be linked to LDL oxidation. In this study, the levels of total cholesterol, iron, protein, conjugated diene (CD), lipid hydroperoxide (LOOH), and thiobarbituric acid reactive substances (TBARs) were determined in HDL from healthy volunteers and patients with β-thalassemia intermedia with hemoglobin E (β-thal/Hb E). The protective activity of thalassemic HDL on LDL oxidation was also investigated. The iron content of HDL2 and HDL3 from β-thal/HbE patients was higher while the cholesterol content was lower than those in healthy volunteers. Thalassemic HDL2 and HDL3 had increased levels of lipid peroxidation markers i.e., conjugated diene, LOOH, and TBARs. Thalassemic HDL had lower peroxidase activity than control HDL and was unable to protect LDL from oxidation induced by CuSO4. Our findings highlight the oxidative modification and poor protective activity of thalassemic HDL on LDL oxidation which may contribute to cardiovascular complications in thalassemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CD:

Conjugated diene

HDL:

High-density lipoprotein

LDL:

Low-density lipoprotein

LOOH:

Lipid hydroperoxide

OD:

Optical density

TBARs:

Thiobarbituric acid reactive substances

β-thal/Hb E:

β-Thalassemia with hemoglobin E

References

  1. Sorensen S, Rubin E, Polster H, Mohandas N, Schrier S (1990) The role of membrane skeletal-associated alpha-globin in the pathophysiology of beta-thalassemia. Blood 75:1333–1336

    CAS  PubMed  Google Scholar 

  2. Unchern S, Laoharuangpanya N, Phumala N, Sipankapracha P, Pootrakul P, Fucharoen S, Wanachivanawin W, Chantharaksri U (2003) The effects of vitamin E on platelet activity in beta-thalassaemia patients. Br J Haematol 123:738–744

    Article  CAS  PubMed  Google Scholar 

  3. Sutipornpalangkul W, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S (2009) Modification of platelet shape change parameter by oxidized lipoprotein from beta-thalassemia/Hemoglobin E. J Med Assoc Thai 92:504–509

    PubMed  Google Scholar 

  4. Kukongviriyapan V, Somparn N, Senggunprai L, Prawan A, Kukongviriyapan U, Jetsrisuparb A (2008) Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia. Pediatr Cardiol 29:130–135

    Article  PubMed  Google Scholar 

  5. Butthep P, Nuchprayoon I, Futrakul N (2004) Endothelial injury and altered hemodynamics in thalassemia. Clin Hemorheol Microcirc 31:287–293

    CAS  PubMed  Google Scholar 

  6. Papanastasiou DA, Siorokou T, Haliotis FA (1996) beta-Thalassaemia and factors affecting the metabolism of lipids and lipoproteins. Haematologia (Budap) 27:143–153

    CAS  Google Scholar 

  7. Maioli M, Cuccuru GB, Pranzetti P, Pacifico A, Cherchi GM (1984) Plasma lipids and lipoproteins pattern in beta-thalassemia major. Acta Haematol 71:106–110

    Article  CAS  PubMed  Google Scholar 

  8. Maioli M, Vigna GB, Tonolo G, Brizzi P, Ciccarese M, Donega P, Maioli M, Fellin R (1997) Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in beta-thalassemia. Atherosclerosis 131:127–133

    Article  CAS  PubMed  Google Scholar 

  9. Goldfarb AW, Rachmilewitz EA, Eisenberg S (1991) Abnormal low and high density lipoproteins in homozygous beta-thalassaemia. Br J Haematol 79:481–486

    Article  CAS  PubMed  Google Scholar 

  10. Altamentova SM, Marva E, Shaklai N (1997) Oxidative interaction of unpaired hemoglobin chains with lipids and proteins: a key for modified serum lipoproteins in thalassemia. Arch Biochem Biophys 345:39–46

    Article  CAS  PubMed  Google Scholar 

  11. Livrea MA, Tesoriere L, Maggio A, D’Arpa D, Pintaudi AM, Pedone E (1998) Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-thalassemia. Blood 92:3936–3942

    CAS  PubMed  Google Scholar 

  12. Tesoriere L, D’Arpa D, Maggio A, Giaccone V, Pedone E, Livrea MA (1998) Oxidation resistance of LDL is correlated with vitamin E status in beta-thalassemia intermedia. Atherosclerosis 137:429–435

    Article  CAS  PubMed  Google Scholar 

  13. Brizzi P, Isaja T, D’Agata A, Malaguarnera L, Malaguarnera M, Musumeci S (2002) Oxidized LDL antibodies (OLAB) in patients with beta-thalassemia major. J Atheroscler Thromb 9:139–144

    CAS  PubMed  Google Scholar 

  14. Stakos DA, Tavridou A, Margaritis D, Tziakas DN, Kotsianidis I, Chalikias GK, Tsatalas K, Bourikas G, Manolopoulos VG, Boudoulas H (2009) Oxidised low-density lipoprotein and arterial function in beta-thalassemia major. Eur J Haematol 82:477–483

    Article  CAS  PubMed  Google Scholar 

  15. Hahalis G, Kremastinos DT, Terzis G, Kalogeropoulos AP, Chrysanthopoulou A, Karakantza M, Kourakli A, Adamopoulos S, Tselepis AD, Grapsas N et al (2008) Global vasomotor dysfunction and accelerated vascular aging in beta-thalassemia major. Atherosclerosis 198:448–457

    Google Scholar 

  16. Mackness MI, Abbott C, Arrol S, Durrington PN (1993) The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 294(Pt 3):829–834

    CAS  PubMed  Google Scholar 

  17. Mackness MI, Durrington PN (1995) HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 115:243–253

    Article  CAS  PubMed  Google Scholar 

  18. Christison J, Karjalainen A, Brauman J, Bygrave F, Stocker R (1996) Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ. Biochem J 314(Pt 3):739–742

    CAS  PubMed  Google Scholar 

  19. Christison JK, Rye KA, Stocker R (1995) Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J Lipid Res 36:2017–2026

    CAS  PubMed  Google Scholar 

  20. Parthasarathy S, Barnett J, Fong LG (1990) High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044:275–283

    CAS  PubMed  Google Scholar 

  21. Klimov AN, Nikiforova AA, Pleskov VM, Kuz’min AA, Kalashnikova NN (1989) Protective effect of high density lipoproteins, their subfractions and lecithin-cholesterol-acyltransferases on the peroxidation modification of low density lipoproteins. Biokhimiia 54:118–123

    CAS  PubMed  Google Scholar 

  22. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA (1995) Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95:774–782

    Article  CAS  PubMed  Google Scholar 

  23. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590

    Article  CAS  PubMed  Google Scholar 

  24. Kunitake ST, Jarvis MR, Hamilton RL, Kane JP (1992) Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci USA 89:6993–6997

    Article  CAS  PubMed  Google Scholar 

  25. Goulinet S, Chapman MJ (1997) Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol 17:786–796

    CAS  PubMed  Google Scholar 

  26. Selek S, Aslan M, Horoz M, Gur M, Erel O (2007) Oxidative status and serum PON1 activity in beta-thalassemia minor. Clin Biochem 40:287–291

    Article  CAS  PubMed  Google Scholar 

  27. Phumala Morales N, Cherlermchoung C, Fucharoen S, Chantharaksri U (2007) Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients. Clin Chem Lab Med 45:884–889

    Article  PubMed  Google Scholar 

  28. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345–1353

    Article  CAS  PubMed  Google Scholar 

  29. Markwell MA, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206–210

    Article  CAS  PubMed  Google Scholar 

  30. White JM, Flashka HA (1973) An automated procedure, with use of ferrozine, for assay of serum iron and total iron-binding capacity. Clin Chem 19:526–528

    CAS  PubMed  Google Scholar 

  31. Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6:67–75

    Article  CAS  PubMed  Google Scholar 

  32. Kleinveld HA, Hak-Lemmers HL, Stalenhoef AF, Demacker PN (1992) Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 38:2066–2072

    CAS  PubMed  Google Scholar 

  33. Mihaljevic B, Katusin-Razem B, Razem D (1996) The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med 21:53–63

    Article  CAS  PubMed  Google Scholar 

  34. Kovachich GB, Mishra OP (1980) Lipid peroxidation in rat brain cortical slices as measured by the thiobarbituric acid test. J Neurochem 35:1449–1452

    Article  CAS  PubMed  Google Scholar 

  35. Ohta T, Takata K, Horiuchi S, Morino Y, Matsuda I (1989) Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein. FEBS Lett 257:435–438

    Article  CAS  PubMed  Google Scholar 

  36. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M (1995) Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882–2891

    Article  CAS  PubMed  Google Scholar 

  37. Hahn M, Subbiah MT (1994) Significant association of lipid peroxidation products with high density lipoproteins. Biochem Mol Biol Int 33:699–704

    CAS  PubMed  Google Scholar 

  38. Sakuma N, Saeki T, Yajima K, Hibino T, Yoshida T, Mizuno H, Mukai S, Sakata S, Kunimatsu M, Kimura G (2005) Both HDL3 and HDL2 exert a powerful anti-oxidative and protective effect against acceleration of oxidative modification of LDL by ascorbic acid. J Nutr Sci Vitaminol (Tokyo) 51:75–79

    CAS  Google Scholar 

  39. Singh K, Chander R, Kapoor NK (1997) High density lipoprotein subclasses inhibit low density lipoprotein oxidation. Indian J Biochem Biophys 34:313–318

    CAS  PubMed  Google Scholar 

  40. Bergmeier C, Siekmeier R, Gross W (2004) Distribution spectrum of paraoxonase activity in HDL fractions. Clin Chem 50:2309–2315

    Article  CAS  PubMed  Google Scholar 

  41. Vakili L, Hama S, Kim JB, Tien D, Safarpoor S, Ly N, Vakili G, Hough G, Navab M (2010) The effect of HDL mimetic peptide 4F on PON1. Adv Exp Med Biol 660:167–172

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Prof. Dr. Suthat Fucharoen, Prof. Dr. Pensri Pootrakul from Thalassemia Research Center, Institute of Science and Technology for Research and Development, Mahidol University; Dr. Wanchai Wanachivanawin from Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University for screening and care of thalassemic patients. We also thank to all staffs and blood donors of Blood Bank Ramathibodi Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nathawut Sibmooh.

About this article

Cite this article

Unchern, S., Laohareungpanya, N., Sanvarinda, Y. et al. Oxidative Modification and Poor Protective Activity of HDL on LDL Oxidation in Thalassemia. Lipids 45, 627–633 (2010). https://doi.org/10.1007/s11745-010-3435-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11745-010-3435-y

Keywords

Navigation